June 8, 2026
Robert L. Ferris, MD, PhD, will begin his term as the organization's vice president on January 1, 2027. SITC is the world’s leading professional society dedicated to advancing the science and application of cancer immunotherapy.
May 28, 2026
A new form of immunotherapy called tumor-infiltrating lymphocyte (TIL) therapy is offering hope to some patients with metastatic melanoma who have few remaining treatment options.
May 26, 2026
UNC Lineberger's Justin Milner, PhD, has emerged in recent years as a young scientist to watch in the field of cancer immunology.
May 14, 2026
Gianpietro Dotti, MD, Paul Armistead, MD, PhD, and colleagues have created a new cellular immunotherapy that targets acute myeloid leukemia (AML) cells without impacting normal blood production, which is one of the major challenges associated with AML treatment.
May 14, 2026
H. Kay Chung, PhD, received a Chan Zuckerberg Biohub Synthetic Biology Award to rewire T cell signaling in cancer, enabling T cells to reinterpret tumor-derived cues and sustain anti-tumor activity.
May 4, 2026
April 29, 2026
Kristy Ainslie, PhD, and colleagues were awarded a $12.8 million NIH Program Project grant to form a collaborative team researching biomaterials to boost the body’s own immune system to enhance cell-based immunotherapy to fight glioblastoma.
April 27, 2026
April 24, 2026
Justin Milner, PhD, and Carla Chibwesha, MD, MSc, have each received a $1 million grant from AACR. The investment will support their work aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.
April 21, 2026